Biography: Graeme Milligan Ph.D., FBPharmacolS, FRSE, FMedSci
1976-1979: University of Birmingham: Graduated with B.Sc. (Hons. 1st class) Biochemistry.
1979-1982: University of Nottingham: Graduated with Ph.D.
1982-1985: Fogarty International Visiting Fellow, National Institute of Mental Health
Bethesda, MD. U.S.A.
1994-present: Professor of Molecular Pharmacology, University of Glasgow, Glasgow, Scotland, U.K.
2010-present: Dean of Research, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, U.K.
2012-present: Gardiner Professor of Biochemistry, University of Glasgow, Glasgow, Scotland, U.K.
I was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and of the Academy of Medical Sciences in 2016.
I was awarded the JR Vane Medal for Pharmacology in 2016 by the British Pharmacological Society.
I co-founded Caldan Therapeutics (http://www.caldantherapeutics.com/) in 2015 and licensed technologies that promoted the start-up of both Cara Therapeutics (http://www.caratherapeutics.com/) (in 2004) and Arena Pharmaceutics (http://www.arenapharm.com/ )(in 1997).
My main research group centres on the function, structure and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. I have published more than 500 peer-reviewed articles on these topics. My research has been cited more than 22,000 times and I am a Thompson Reuters 2014 and 2016 Highly Cited Researcher (http://highlycited.com/).